| Total | $38.8M |
| Series B, 11/03 InterWest Partners Skyline Ventures InterSouth Partners MedImmune Ventures | $27M |
| Series C, 6/09 InterSouth Partners InterWest Partners MedImmune Ventures | $11.8M |
Applied Genetic Technologies Corporation (AGTC) specializes in the use of viral vectors for Gene Therapy.